CIK 0001438533 · Large accelerated filer
Travere Therapeutics, Inc.
Sign in to watch- Ticker
- TVTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- operating
- EIN
- 262383102
- Phone
- 888-969-7879
- Business address
- 3611 VALLEY CENTRE DR, SUITE 300, SAN DIEGO, CA, 92130
- Former names
- Retrophin, Inc., Desert Gateway, Inc.
- 144 Insider Sale of Securities
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Planned sale SVP, CHIEF ACCOUNTING OFFICER sold 67,115 shares at $36.00 ($2,416,140)
- 144 Insider Sale of Securities
- 4 Planned sale Director sold 18,000 shares at $35.03 ($630,601)
- 4 Planned sale CHIEF COMMERCIAL OFFICER sold 5,591 shares at $35.00 ($195,685)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 4 Planned sale CHIEF EXECUTIVE OFFICER sold 120,000 shares at an average $30.32 ($3,638,432)
- 4 Planned sale CHIEF COMMERCIAL OFFICER sold 2,662 shares at $30.00 ($79,860)
- 8-K Event Results of operations
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Gift CHIEF COMMERCIAL OFFICER gave 891 shares (gift)
- 4 Planned sale Chief Legal Officer and GC sold 10,000 shares at $25.00 ($250,000)
- 144 Insider Sale of Securities
Page 10 of 65 · 1,286 filings